1. Home
  2. IGC vs FMST Comparison

IGC vs FMST Comparison

Compare IGC & FMST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • FMST
  • Stock Information
  • Founded
  • IGC 2005
  • FMST 2005
  • Country
  • IGC United States
  • FMST Canada
  • Employees
  • IGC N/A
  • FMST N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • FMST Other Metals and Minerals
  • Sector
  • IGC Health Care
  • FMST Basic Materials
  • Exchange
  • IGC Nasdaq
  • FMST Nasdaq
  • Market Cap
  • IGC 33.5M
  • FMST 28.2M
  • IPO Year
  • IGC N/A
  • FMST N/A
  • Fundamental
  • Price
  • IGC $0.37
  • FMST $2.24
  • Analyst Decision
  • IGC Strong Buy
  • FMST
  • Analyst Count
  • IGC 2
  • FMST 0
  • Target Price
  • IGC $3.88
  • FMST N/A
  • AVG Volume (30 Days)
  • IGC 7.5M
  • FMST 331.0K
  • Earning Date
  • IGC 08-07-2025
  • FMST 01-01-0001
  • Dividend Yield
  • IGC N/A
  • FMST N/A
  • EPS Growth
  • IGC N/A
  • FMST N/A
  • EPS
  • IGC N/A
  • FMST N/A
  • Revenue
  • IGC $1,271,000.00
  • FMST N/A
  • Revenue This Year
  • IGC $15.26
  • FMST N/A
  • Revenue Next Year
  • IGC $3.41
  • FMST N/A
  • P/E Ratio
  • IGC N/A
  • FMST N/A
  • Revenue Growth
  • IGC N/A
  • FMST N/A
  • 52 Week Low
  • IGC $0.25
  • FMST $0.55
  • 52 Week High
  • IGC $0.48
  • FMST $5.74
  • Technical
  • Relative Strength Index (RSI)
  • IGC 54.60
  • FMST 37.70
  • Support Level
  • IGC $0.30
  • FMST $2.17
  • Resistance Level
  • IGC $0.46
  • FMST $2.52
  • Average True Range (ATR)
  • IGC 0.04
  • FMST 0.23
  • MACD
  • IGC 0.00
  • FMST -0.06
  • Stochastic Oscillator
  • IGC 33.00
  • FMST 6.48

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About FMST Foremost Lithium Resource & Technology Ltd. Common stock

Foremost Clean Energy Ltd is an emerging North American uranium and lithium exploration company. Its uranium portfolio consists of projects at different stages of exploration from grassroots, to those with historical exploration and drill-ready targets. It also maintains a secondary portfolio of lithium projects at different stages of development spanning 50,000-plus acres across Manitoba and Quebec. Geographically it covers Canada and United states.

Share on Social Networks: